FemPulse
Business Services · Minnesota, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 342, Willernie, Minnesota, 55090,...Phone Number
(612) 940-0349Website
www.fempulse.comRevenue
<$5 MillionIndustry
About FemPulse
FemPulse Org Chart
Is FemPulse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if FemPulse has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when FemPulse launches new products
Website visits: Recent activity has been detected on your website
Check out if FemPulse is spiking on competitors!
Click to see if FemPulse had a recent Job posting/layoffs
Earning: See what the market has to say on FemPulse recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once FemPulse has new funding data
FemPulse, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at FemPulse
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to FemPulse
Compare insights from companies similar to FemPulse, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FemPulse is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
FemPulse is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about FemPulse.
FemPulse Tech Stack
A closer look at the technologies used by FemPulse
FemPulse News & Media
FemPulse Positive Clinical Data To Be Presented at SUFU Conference
SAN FRANCISO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder, announced today that an abstract describing the company’s two recent usability studies was selected for presentation at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) annual conference in San Juan, Puerto Rico on Friday, February 27, 2026.Medical AI Expert Wido Menhardt Joins FemPulse Scientific Advisory Board
SAN FRANCISCO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- FemPulseTM, a bioelectronic medical technology company with first application overactive bladder, announced today that medical AI expert Wido Menhardt, PhD has joined the company’s Scientific Advisory Board.FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women
SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II pivotal clinical trial in female patients suffering from overactive bladder (OAB). OAB is the first application of FemPulse’s patented female health platform.FemPulse Announces Issuance of Patents in China and Australia
MINNEAPOLIS, Jan. 06, 2020 (GLOBE NEWSWIRE) -- FemPulse Corporation (FemPulse), a private, clinical-stage bioelectronic medicine company developing a novel therapy for the personalized treatment of overactive bladder (OAB) in women, today announced the issuance of two patents from China and Australia covering methods of stimulation of autonomic nerve plexuses in women.
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding FemPulse
FemPulse Corporation specializes in the development of medical devices aimed at improving women's health. Currently, their products are not cleared or approved for sale in the United States or other markets, and they are primarily intended for controlled clinical investigations. The company targets healthcare professionals and researchers intereste... Read More
